Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Jentadueto®:Boehringer Ingelheim (Schweiz) GmbH
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
A10BD11 - Metformin and LinagliptinATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
A10 - Drugs Used in Diabetes
A10B - Blood Glucose Lowering Drugs, Excl. Insulins

Fixed combinations of blood glucose lowering drugs and lipid modifying agentes are classified here.

A10BD - Combinations Of Oral Blood Glucose Lowering Drugs

Combinations with thioctic acid are allowed in A10BD05.

It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components. One UD is the fixed DDD for products dosed as 1 tablet daily whereas two UD is the fixed DDD for products dosed as 2 tablets daily. The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.
See list of DDDs for combined products,

A10BD11 - Metformin and Linagliptin
2022 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home